Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Nivolumab for the Treatment of Advanced Pediatric Malignancies

AGATA MARJAŃSKA, MONIKA DROGOSIEWICZ, BOŻENNA DEMBOWSKA-BAGIŃSKA, KATARZYNA PAWIŃSKA-WĄSIKOWSKA, WALENTYNA BALWIERZ, KATARZYNA BOBEFF, WOJCIECH MŁYNARSKI, AGNIESZKA MIZIA-MALARZ, ANNA RACIBORSKA, MARIUSZ WYSOCKI and JAN STYCZYŃSKI
Anticancer Research December 2020, 40 (12) 7095-7100; DOI: https://doi.org/10.21873/anticanres.14738
AGATA MARJAŃSKA
1Department of Pediatric, Hematology and Oncology, Nicolaus Copernicus University Torun, Jurasz University Hospital, Collegium Medicum, Bydgoszcz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: agata.marjanska{at}wp.pl
MONIKA DROGOSIEWICZ
2Department of Oncology, The Children’s Memorial Health Institute, Warsaw, Poland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BOŻENNA DEMBOWSKA-BAGIŃSKA
2Department of Oncology, The Children’s Memorial Health Institute, Warsaw, Poland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATARZYNA PAWIŃSKA-WĄSIKOWSKA
3Department of Pediatric, Oncology and Hematology, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WALENTYNA BALWIERZ
3Department of Pediatric, Oncology and Hematology, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATARZYNA BOBEFF
4Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WOJCIECH MŁYNARSKI
4Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AGNIESZKA MIZIA-MALARZ
5Department of Pediatric, Oncology, Hematology and Chemotherapy, Upper Silesia Children’s Care Health Centre, Medical University of Silesia, Katowice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNA RACIBORSKA
6Department of Oncology and Surgical Oncology for Children and Youth, Institute of Mother and Child, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIUSZ WYSOCKI
1Department of Pediatric, Hematology and Oncology, Nicolaus Copernicus University Torun, Jurasz University Hospital, Collegium Medicum, Bydgoszcz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAN STYCZYŃSKI
1Department of Pediatric, Hematology and Oncology, Nicolaus Copernicus University Torun, Jurasz University Hospital, Collegium Medicum, Bydgoszcz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Overall survival: (A) for the entire group; (B) depending on ECOG score; (C) depending on number of previous lines of therapy; (D) depending on primary diagnosis.

Tables

  • Figures
  • Table I.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 12
December 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nivolumab for the Treatment of Advanced Pediatric Malignancies
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Nivolumab for the Treatment of Advanced Pediatric Malignancies
AGATA MARJAŃSKA, MONIKA DROGOSIEWICZ, BOŻENNA DEMBOWSKA-BAGIŃSKA, KATARZYNA PAWIŃSKA-WĄSIKOWSKA, WALENTYNA BALWIERZ, KATARZYNA BOBEFF, WOJCIECH MŁYNARSKI, AGNIESZKA MIZIA-MALARZ, ANNA RACIBORSKA, MARIUSZ WYSOCKI, JAN STYCZYŃSKI
Anticancer Research Dec 2020, 40 (12) 7095-7100; DOI: 10.21873/anticanres.14738

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Nivolumab for the Treatment of Advanced Pediatric Malignancies
AGATA MARJAŃSKA, MONIKA DROGOSIEWICZ, BOŻENNA DEMBOWSKA-BAGIŃSKA, KATARZYNA PAWIŃSKA-WĄSIKOWSKA, WALENTYNA BALWIERZ, KATARZYNA BOBEFF, WOJCIECH MŁYNARSKI, AGNIESZKA MIZIA-MALARZ, ANNA RACIBORSKA, MARIUSZ WYSOCKI, JAN STYCZYŃSKI
Anticancer Research Dec 2020, 40 (12) 7095-7100; DOI: 10.21873/anticanres.14738
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs)
  • Google Scholar

More in this TOC Section

  • Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures
  • Surgical Outcomes and Postoperative Changes in Nutritional Indexes and Sarcopenia Markers in Oldest-old Patients With Resected Biliary Tract Cancer: A Retrospective Cohort Study
  • Effect of Tissue Sample Type on The Evaluation of PD-L1 (SP142) Expression in Breast Cancer
Show more Clinical Studies

Similar Articles

Keywords

  • nivolumab
  • ipilimumab
  • anti-PD-1
  • pediatric cancer
  • malignant melanoma
  • brain tumor
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire